WS #11711

From 498 msgs · 8 key-dev
Holding: newest synthesis is 135d 13h old

AstraZeneca and Ionis' Wainua fails Phase 3 ATTR-CM trial, causing AZN stock to slump 11% and IONS to plummet; competitors ALNY and BBIO surge.

AstraZeneca/Ionis Drug Trial Failure

AstraZeneca and Ionis' Wainua fails Phase 3 ATTR-CM trial, causing AZN stock to slump 11% and IONS to plummet; competitors ALNY and BBIO surge.

Full world state #11711 →